Drawing for MAXIPURE

USPTO serial 79420187

MAXIPURE

Reviewed by CopyMark Law Group

Reg. 8258218Status 700Registered
Filing date
Status date
Registration date
May 19, 2026
Examiner
GUZICK, LEAH A
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MAXIPURE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Scott D. Woldow

Scott D. Woldow Smith, Gambrell & Russell, LLP1055 Thomas Jefferson Street, NWSuite 400Washington, DC 20007

Goods and services

ClassDescriptionStatusFirst use
001Chemical additives for use in the manufacture of pharmaceuticals; chemical excipients and chemical intermediates for use in the manufacture of pharmaceutical products; amino acids for industrial purposes; peptides substrates for industrial purposes; proteins for use in industry, proteins for the food industry; proteins for use in pharmaceutical and nutritional product manufacturing; saccharide preparations, used as an ingredient in the manufacture of pharmaceutical and nutritional products, other than for medical use; galactose for industrial pharmaceutical and nutritional purposes; mannose for industrial purposes; antioxidants for use in the manufacture of pharmaceuticals; lipids for use in industry, namely, used in the manufacture of cosmetics, beverages, food products and food supplements; chemical preparations for use in the food industry; chemical preparations for the manufacture of food supplements; chemical excipients and chemical intermediate products for use in the manufacture of foodstuffs, in particular food supplements; chemical additives for use in the manufacture of probiotic products; chemical additives for use in the manufacture of pharmaceuticals, foodstuffs and pharmaceutical products; probiotic bacterial formulations, other than for medical use and veterinary use; bacteria for use in food manufacture; bacterial preparations for the food industry; probiotic bacteria for the food industry; bacterial cultures for addition to food products; probiotic bacterial cultures for the food industry; milk ferments for the food industry; bacteria for use in the manufacture of food supplements, food, nutritional products, pharmaceutical products and cosmetics; bacteriological cultures mediums, other than for medical and veterinary use; bacterial products, other than for medical and veterinary use; bacterial preparations, other than for medical and veterinary use; chemical analysis diagnostic kits comprising specimen receptors and reagents for testing for selected bacteria, other than for medical or veterinary purposes; catalysts, in particular biochemical catalysts; chemical substances for preserving foodstuffs; all the foregoing for use in connection with the manufacture of cosmetics, food products, and pharmaceutical products and none of the aforesaid products for use in the manufacture of insecticides, adjuvants, agricultural chemicals, forestry, horticulture, energy and well drilling.ACTIVE—
005Pharmaceutical and veterinary preparations for the treatment of nutritional conditions, bacteriological conditions, and probiotic conditions; bacterial preparations for medical and veterinary preparations; chemical preparations for medical, pharmaceutical and veterinary purposes, namely, nucleic acid sequences and chemical reagents; veterinary preparations, namely, antioxidants; adjuvants for medical purposes; amino acids for medical and veterinary purposes; amino acid preparations for medical, veterinary and pharmaceutical purposes; synthetic peptides for pharmaceutical purposes for the treatment of nutritional conditions; cellulose esters, fats, and oils for medical and veterinary uses; salts, in particular potassium and sodium salts for medicinal purposes; steroids; biological preparations for the treatment of probiotic conditions for medical and veterinary purposes; ferments for pharmaceutical purposes; yeast for dietary and pharmaceutical purposes; starch for dietary and pharmaceutical purposes; enzymes and enzyme preparations for medical and veterinary purposes; bacterial and bacteriological preparations for medical or veterinary purposes; bacterial poisons; cultures of microorganisms for medical or veterinary use; nutritive substances for microorganisms for medical or veterinary purposes; bouillons for bacteriological cultures for medical purposes or veterinary purposes; biological tissue cultures for medical and veterinary purposes; pharmaceutical preparations and substances for the treatment of damaged skin and tissue, namely, tissue-regenerative preparations; probiotic supplements; probiotic bacterial formulations for veterinary use; probiotic bacterial formulations for medical use; probiotic preparations for dietary purposes; probiotic preparations for medical use to help maintain a natural flora in the digestive system; probiotic preparations for medicinal purposes to maintain a natural flora in the digestive system; dietetic foods and beverages adapted for medical and veterinary purposes; dietetic foods adapted for medical purposes; albuminous preparations for medical purposes, namely, albumin dietary supplements; candy, medicated; medicinal drinks; dietetic beverages adapted for medical purposes; medical preparations for slimming purposes; food for babies; dietary supplements for human beings; dietary supplements for animals; dietary supplements; dietetic preparations adapted for medical use; capsules sold empty for pharmaceutical purposes; sugar, in particular rock sugar and dextrose for medical purposes; glucose for medical purposes; albuminous foodstuffs for medical purposes, namely, albumin supplements; protein dietary supplements; dietary fiber for treating constipation; mineral dietary supplements; chemical preparations, namely, preparations of trace elements for medical and veterinary use, namely, for nutritional diseases, illnesses, and conditions; vitamin preparations.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 10, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Aug 27, 2026ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Aug 26, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 26, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Aug 19, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 19, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 19, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 19, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 31, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 31, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 25, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 5, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 5, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Mar 5, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 5, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 5, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 12, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 12, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 12, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 2, 2025RFNTREFUSAL PROCESSED BY IB—
Jul 11, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 11, 2025RFRRREFUSAL PROCESSED BY MPU—
May 15, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 14, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 1, 2025DOCKASSIGNED TO EXAMINER—
Mar 31, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 31, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 27, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance